Platelet-Activating Factor Induces Du-al-Specificity Phosphatase 1 and 5 Gene Expression


Platelet-activating factor (PAF) is a potent inflammatory phospholipid mediator that is known to play a role in early-phase responses in asthma and other diseases. Through its high affinity receptor, PAFR, PAF is known to activate multiple signalling pathways contributing to its proinflammatory effects. Of these pathways, the mitogen-activated protein kinase (MAPK) cascade is initiated upon PAF stimulation, leading to the activation of the conventional MAPKs ERK1/2, p38 and JNK. Since dual-specificity phosphatases (DUSP) downregulated MAPK activity, we postulated that PAF could also enhance DUSP expression and thus induced an autoregulatory loop. In this report, we studied the effect of PAF on DUSP mRNA expression in human monocytes. Our results demonstrate that PAF induces DUSP1 and DUSP5 gene expression in a time- and concentration-dependent manner, with maximal effects at PAF 100 nM and at 20 - 30 min of stimulation. In contrast, DUSP2 and DUSP6 gene expression was not enhanced by PAF. Moreover, leukotriene D4, another lipid mediator of inflammation, was unable to modulate DUSP expression. PAF-induced DUSP expression was prevented by the PAFR antagonist WEB2170 and by pretreatment with the transcriptional inhibitor Actinomycin D. Moreover, enhanced DUSP5, but not DUSP1 expression was prevented by pretreatment with the ERK inhibitor PD98059 or the PI3K inhibitor Wortmannin. Taken together, our results indicate that PAF selectively enhances DUSP1 and DUSP5 gene expressions through PAFR activation, and suggest that PAF may have an active role in the resolution of inflammation by its ability to upregulate the two DUSPs and thus provide a negative auto-regulatory signalling mechanism.

Share and Cite:

Lapointe, F. , Stiffel, M. , Auger, J. , Rola-Pleszczynski, M. and Stankova, J. (2015) Platelet-Activating Factor Induces Du-al-Specificity Phosphatase 1 and 5 Gene Expression. Pharmacology & Pharmacy, 6, 442-450. doi: 10.4236/pp.2015.69046.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Izumi, T. and Shimizu, T. (1995) Platelet-Activating Factor Receptor: Gene Expression and Signal Transduction. Biochimica et Biophysica Acta, 3, 317-333.
[2] Kasperska-Zajac, A., Brzoza, Z. and Rogala, B. (2008) Platelet Activating Factor as a Mediator and Therapeutic Approach in Bronchial Asthma. Inflammation, 2, 112-120.
[3] Marques, S.A., Dy, L.C., Southall, M.D., Yi, Q., Smietana, E., Kapur, R., Marques, M., Travers, J.B. and Spandau, D.F. (2002) The Platelet-Activating Factor Receptor Activates the Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and Induces Proliferation of Epidermal Cells through an Epidermal Growth Factor-Receptor-Dependent Pathway. Journal of Pharmacology and Experimental Therapeutics, 3, 1026-1035.
[4] Honda, Z., Takano, T., Gotoh, Y., Nishida, E., Ito, K. and Shimizu, T. (1994) Transfected Platelet-Activating Factor Receptor Activates Mitogen-Activated Protein (Map) Kinase and Map Kinase Kinase in Chinese Hamster Ovary Cells. Journal of Biological Chemistry, 3, 2307-2315.
[5] Chen, Z., Rola-Pleszczynski, M. and Stankova, J. (2003) Activation of Erk1/2 by Platelet-Activating Factor Receptor Is Independent of Receptor Internalization and G-Protein Activation. Cell Signal, 9, 843-850.
[6] Nick, J.A., Avdi, N.J., Young, S.K., Knall, C., Gerwins, P., Johnson, G.L. and Worthen, G.S. (1997) Common and Distinct Intracellular Signaling Pathways in Human Neutrophils Utilized by Platelet Activating Factor and Fmlp. Journal of Clinical Investigation, 5, 975-986.
[7] Maruoka, S., Hashimoto, S., Gon, Y., Takeshita, I. and Horie, T. (2000) PAF-Induced Rantes Production by Human Airway Smooth Muscle Cells Requires Both P38 Map Kinase and Erk. American Journal of Respiratory and Critical Care, 161, 922-929.
[8] Miike, S., Kurasawa, K., Saito, Y. and Iwamoto, I. (2000) Platelet-Activating Factor Activates Mitogen-Activated Protein Kinases through the Activation of Phosphatidylinositol 3-Kinase and Tyrosine Kinase in Human Eosinophils. Journal of Leukocyte Biology, 1, 117-126.
[9] Patterson, H., Nibbs, R., McInnes, I. and Siebert, S. (2014) Protein Kinase Inhibitors in the Treatment of Inflammatory and Autoimmune Diseases. Clinical & Experimental Immunology, 1, 1-10.
[10] Caunt, C.J. and Keyse, S.M. (2013) Dual-Specificity Map Kinase Phosphatases (Mkps): Shaping the Outcome of Map Kinase Signalling. FEBS Journal, 2, 489-504.
[11] Hendriks, W.J., Elson, A., Harroch, S., Pulido, R., Stoker, A. and den Hertog, J. (2013) Protein Tyrosine Phosphatases in Health and Disease. FEBS Journal, 280, 708-730.
[12] Wancket, L.M., Frazier, W.J. and Liu, Y. (2012) Mitogen-Activated Protein Kinase Phosphatase (Mkp)-1 in Immunology, Physiology, and Disease. Life Sciences, 90, 237-248.
[13] Bhavsar, P., Hew, M., Khorasani, N., Torrego, A., Barnes, P.J., Adcock, I. and Chung, K.F. (2008) Relative Corticosteroid Insensitivity of Alveolar Macrophages in Severe Asthma Compared with Non-Severe Asthma. Thorax, 63, 784-790.
[14] Mandl, M., Slack, D.N. and Keyse, S.M. (2005) Specific Inactivation and Nuclear Anchoring of Extracellular Signal-Regulated Kinase 2 by the Inducible Dual-Specificity Protein Phosphatase DUSP5. Molecular and Cellular Biology, 25, 1830-1845.
[15] Halle, M., Gabrielsen, A., Paulsson-Berne, G., Gahm, C., Agardh, H.E., Farnebo, F. and Tornvall, P. (2010) Sustained Inflammation Due to Nuclear Factor-Kappa B Activation in Irradiated Human Arteries. Journal of the American College of Cardiology, 55, 1227-1236.
[16] Temple, R., Allen, E., Fordham, J., Phipps, S., Schneider, H.C., Lindauer, K., Hayes, I., Lockey, J., Pollock, K. and Jupp, R. (2001) Microarray Analysis of Eosinophils Reveals a Number of Candidate Survival and Apoptosis Genes. American Journal of Respiratory Cell and Molecular Biology, 25, 425-433.
[17] Boyum, A. (1968) Separation of Leukocytes from Blood and Bone Marrow. Introduction. Scandinavian Journal of Clinical and Laboratory Investigation, 97, 77-89.
[18] Dussault, A.A. and Pouliot, M. (2006) Rapid and Simple Comparison of Messenger RNA Levels Using Real-Time PCR. Biological Procedures Online, 8, 1-10.
[19] Manetsch, M., Che, W., Seidel, P., Chen, Y. and Ammit, A.J. (2012) Mkp-1: A Negative Feedback Effector That Represses Mapk-Mediated Pro-Inflammatory Signaling Pathways and Cytokine Secretion in Human Airway Smooth Muscle Cells. Cellular Signalling, 24, 907-913.
[20] Hu, J.H., Chen, T., Zhuang, Z.H., Kong, L., Yu, M.C., Liu, Y., Zang, J.W. and Ge, B.X. (2007) Feedback Control of Mkp-1 Expression by P38. Cellular Signalling, 19, 393-400.
[21] Hay, D.W., Torphy, T.J. and Undem, B.J. (1995) Cysteinyl Leukotrienes in Asthma: Old Mediators up to New Tricks. Trends in Pharmacological Sciences, 16, 304-309.
[22] Chi, H., Barry, S.P., Roth, R.J., Wu, J.J., Jones, E.A., Bennett, A.M. and Flavell, R.A. (2006) Dynamic Regulation of Pro- and Anti-Inflammatory Cytokines by MAPK Phosphatase 1 (MKP-1) in Innate Immune Responses. Proceedings of the National Academy of Sciences of the United States of America, 103, 2274-2279.
[23] Kwak, S.P. and Dixon, J.E. (1995) Multiple Dual Specificity Protein Tyrosine Phosphatases Are Expressed and Regulated Differentially in Liver Cell Lines. The Journal of Biological Chemistry, 270, 1156-1160.
[24] Hendriks, W.J. and Pulido, R. (2013) Protein Tyrosine Phosphatase Variants in Human Hereditary Disorders and Disease Susceptibilities. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1832, 1673-1696.
[25] Shah, S., King, E.M., Chandrasekhar, A. and Newton, R. (2014) Roles for the Mitogen-Activated Protein Kinase (MAPK) Phosphatase, DUSP1, in Feedback Control of Inflammatory Gene Expression and Repression by Dexamethasone. The Journal of Biological Chemistry, 289, 13667-13679.
[26] Quante, T., Ng, Y.C., Ramsay, E.E., Henness, S., Allen, J.C., Parmentier, J., Ge, Q. and Ammit, A.J. (2008) Corticosteroids Reduce Il-6 in Asm Cells via Up-Regulation of MKP-1. American Journal of Respiratory Cell and Molecular Biology, 39, 208-217.
[27] Jin, Y., Hu, D., Peterson, E.L., Eng, C., Levin, A.M., Wells, K., Beckman, K., Kumar, R., Seibold, M.A., Karungi, G., Zoratti, A., Gaggin, J., Campbell, J., Galanter, J., Chapela, R., Rodriguez-Santana, J.R., Watson, H.G., Meade, K., Lenoir, M., Rodriguez-Cintron, W., Avila, P.C., Lanfear, D.E., Burchard, E.G. and Williams, L.K. (2010) Dual-Specificity Phosphatase 1 as a Pharmacogenetic Modifier of Inhaled Steroid Response among Asthmatic Patients. Journal of Allergy and Clinical Immunology, 126, 618-625. e2.
[28] Jeffrey, K.L., Brummer, T., Rolph, M.S., Liu, S.M., Callejas, N.A., Grumont, R.J., Gillieron, C., Mackay, F., Grey, S., Camps, M., Rommel, C., Gerondakis, S.D. and Mackay, C.R. (2006) Positive Regulation of Immune Cell Function and Inflammatory Responses by Phosphatase PAC-1. Nature Immunology, 7, 274-283.
[29] Li, C., Scott, D.A., Hatch, E., Tian, X. and Mansour, S.L. (2007) Dusp6 (Mkp3) Is a Negative Feedback Regulator of FGF-Stimulated ERK Signaling During Mouse Development. Development, 134, 167-176.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.